Boston Scientific Corporation: updates and filings

BSXNYSEHealthcare · Surgical & Medical Instruments & Apparatus

Price

$43.64

November 18, 2026Market cap $64.8B

What Ploutos Investor adds for Boston Scientific

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 71 daysAround Jan 28, 2027 · for Q4 2026

last Oct 28, 2026next Jan 28, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 17, 2026 latest annualNov 2, 2026 latest quarterly
  • Nov 17, 2026Officer or director change, other material events
    Form8-K
  • Nov 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 2, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 28, 2026Results of operations
    Form8-K
  • Oct 7, 2026Officer or director change, other material events
    Form8-K
  • Sep 23, 2026Officer or director change
    Form8-K
  • Sep 8, 2026Material cybersecurity incident
    Form8-K
  • Aug 26, 2026Other material events
    Form8-K
  • Aug 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 3, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 29, 2026Results of operations
    Form8-K
  • Jul 27, 2026Restructuring costs
    Form8-K
  • Jun 24, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 21, 2026Conflict minerals report
    FormSD
  • May 18, 2026Other material events
    Form8-K
  • May 18, 2026Other material events
    Form8-K
  • May 8, 2026Shares registered for employees
    FormS-8
  • May 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • May 5, 2026Amended articles or bylaws, shareholder vote
    Form8-K
  • May 1, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 22, 2026Filing
    Form425
  • Apr 22, 2026Results of operations
    Form8-K
  • Apr 1, 2026Filing
    FormEFFECT
  • Mar 30, 2026Correspondence with the SEC
    FormCORRESP

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 9, 1995: every report, 8-K, meeting and letter. Of its other filings (1,087 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 60.

The full analysis

What do Boston Scientific's filings show?

The filings are where every one of Boston Scientific's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.